| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $18.7M | -14.0% |
| SG&A Expense | $6.5M | +98.6% |
| Operating Income | -$25.2M | -0.7% |
| Income Tax | $800 | — |
| Net Income | -$27.3M | -10.3% |
| EPS (Basic) | -$3.26 | +81.1% |
| EPS (Diluted) | -$3.26 | +81.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $8.6M | — |
| Current Assets | $9.2M | +207.4% |
| Total Assets | $9.3M | +211.1% |
| Current Liabilities | $8.8M | +27.2% |
| Total Liabilities | $9.2M | +9.1% |
| Stockholders' Equity | $104K | +100.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$21.8M | -1.0% |
| Financing Cash Flow | $27.5M | +565.8% |